# Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)

> **NCT00018902** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 334 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Fluoxetine
- **DRUG:** Venlafaxine
- **BEHAVIORAL:** Cognitive Behavioral Therapy (CBT)
- **DRUG:** Citalopram

## Key facts

- **NCT ID:** NCT00018902
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 334 (ACTUAL)
- **Last updated:** 2014-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00018902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00018902, "Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00018902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*